Guardado en:
| Autor principal: | Park, Hahnbeom |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.20265844 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
CARACTERIZACIÓN DE LA CONDUCTA ALIMENTARIA INDUCIDA POR AGONISTAS 5-HT1A, 5-HT1B, 5-HT2A y 5-HT2C
por: VERÓNICA ELSA LÓPEZ-ALONSO
Publicado: (2009)
por: VERÓNICA ELSA LÓPEZ-ALONSO
Publicado: (2009)
Serotonin 5‐ HT 7 receptor signaling in neuropsychiatric disorders
por: Eunseo Park, et al.
Publicado: (2026)
por: Eunseo Park, et al.
Publicado: (2026)
The roles of 5‐HT in orofacial pain
por: Zhishan Zou, et al.
Publicado: (2024)
por: Zhishan Zou, et al.
Publicado: (2024)
Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum
por: Jieling Cai, et al.
Publicado: (2024)
por: Jieling Cai, et al.
Publicado: (2024)
Optimized 5‐HT 2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction
por: Saktimayee M. Roy, et al.
Publicado: (2025)
por: Saktimayee M. Roy, et al.
Publicado: (2025)
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
por: Gianfabio Giorgioni, et al.
Publicado: (2024)
por: Gianfabio Giorgioni, et al.
Publicado: (2024)
Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
por: Isabel Werle, et al.
Publicado: (2024)
por: Isabel Werle, et al.
Publicado: (2024)
Biphenylyl‐N‐ethylethanamines induce ERK phosphorylation through 5‐HT7R‐Gs signaling pathway
por: Eunseo Park, et al.
Publicado: (2025)
por: Eunseo Park, et al.
Publicado: (2025)
Low 5HT 1B and 5HT 4 Receptor Neurotransmission as a Potential Link Between Cholesterol Metabolism and Suicide Risk
por: Hans O. Kalkman, et al.
Publicado: (2026)
por: Hans O. Kalkman, et al.
Publicado: (2026)
5‐ HT 6 Receptor Inverse Agonists Modulate Diabetic Neuropathic Pain in Female Rats: Evidence for 5‐ HT 6 Receptor Constitutive Activity
por: Nazarine Mokhtar, et al.
Publicado: (2025)
por: Nazarine Mokhtar, et al.
Publicado: (2025)
Spatiotemporal dynamics of β ‐arrestin‐mediated Src activation in 5‐ HT7 receptor signaling pathway
por: Hyunbin Kim, et al.
Publicado: (2026)
por: Hyunbin Kim, et al.
Publicado: (2026)
5‐HT7R Deficiency Alleviates ADP‐Heptose‐Induced Cognitive Impairment via Inhibiting Ferroptosis and Neuroinflammation in Mice
por: Xiao Zou, et al.
Publicado: (2025)
por: Xiao Zou, et al.
Publicado: (2025)
Decreased Serum 5‐ HT : Clinical Correlates and Regulatory Role in NMJ of MG
por: Xinru Shen, et al.
Publicado: (2025)
por: Xinru Shen, et al.
Publicado: (2025)
Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway
por: Irfan Cinar, et al.
Publicado: (2025)
por: Irfan Cinar, et al.
Publicado: (2025)
Pharmacological characterization and functional roles of the 5‐HT7 receptor for pheromone sensitivity and mating in Helicoverpa armigera
por: Huixin Wang, et al.
Publicado: (2025)
por: Huixin Wang, et al.
Publicado: (2025)
Antagonism of 5‐HT2 receptors attenuates self‐sustained firing of human motor units
por: Benjamin I. Goodlich, et al.
Publicado: (2024)
por: Benjamin I. Goodlich, et al.
Publicado: (2024)
Serine 3.39 and isoleucine 4.60 are key sites for 5‐HT 2A R‐mediated G s signaling
por: Lulu Xie, et al.
Publicado: (2024)
por: Lulu Xie, et al.
Publicado: (2024)
Associação do polimorfismo do gene receptor 5HT-2A e síncope vasovagal
por: Elisiane Lorenzini
Publicado: (2012)
por: Elisiane Lorenzini
Publicado: (2012)
Nuclear magnetic shielding in HD and HT
por: Puchalski, Mariusz, et al.
Publicado: (2022)
por: Puchalski, Mariusz, et al.
Publicado: (2022)
Association Between FABP7‐5‐HT Pattern and Anxiety or Depression in Patients With Psoriasis: A Cross‐Sectional Study
por: Dawei Huang, et al.
Publicado: (2024)
por: Dawei Huang, et al.
Publicado: (2024)
Los antidepresivos inhibidores selectivos de recaptura de serotonina (ISRS, ISR-5HT)
por: Martha Patricia Ontiveros Uribe
Publicado: (2008)
por: Martha Patricia Ontiveros Uribe
Publicado: (2008)
Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity
por: Andreas Gkanas, et al.
Publicado: (2025)
por: Andreas Gkanas, et al.
Publicado: (2025)
Protective Effect of Pediococcus pentosaceus Li05 on Constipation via TGR5/TPH1/5‐HT Activation
por: Hui Chen, et al.
Publicado: (2025)
por: Hui Chen, et al.
Publicado: (2025)
5‐HT 2A receptor agonism by tert ‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence
por: Giorgia Corli, et al.
Publicado: (2026)
por: Giorgia Corli, et al.
Publicado: (2026)
The Effect of Serotonin 5‐HT 2C Receptor Modulation on Binge Drinking and Alcohol‐Seeking in Female Mice
por: Roberta G. Anversa, et al.
Publicado: (2025)
por: Roberta G. Anversa, et al.
Publicado: (2025)
5‐HT7 antagonists confer analgesia via suppression of neurotrophin overproduction in submucosal nerves of mouse models with visceral hypersensitivity
por: Tzu‐Yi Lee, et al.
Publicado: (2025)
por: Tzu‐Yi Lee, et al.
Publicado: (2025)
Chinese Yam ( Dioscorea ) Improves Psychiatric Comorbidities of Colitis Mice Through Regulating 5‐HT Metabolism
por: Yifan Cui, et al.
Publicado: (2026)
por: Yifan Cui, et al.
Publicado: (2026)
Pharmacologic MRI Brain Imaging Studies of Serotonin 5‐ HT 1 Receptor Agonists in Awake Mice
por: Brittany M. Brems, et al.
Publicado: (2026)
por: Brittany M. Brems, et al.
Publicado: (2026)
Clozapine's Molecular Signature: Selective 5‐ HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions
por: Sylwia Kedracka‐Krok, et al.
Publicado: (2025)
por: Sylwia Kedracka‐Krok, et al.
Publicado: (2025)
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
por: Agata Zięba, et al.
Publicado: (2024)
por: Agata Zięba, et al.
Publicado: (2024)
TMT-based quantitative proteomic results from shC and shRAB5IF HT-22 cells
por: Cong, Cao
Publicado: (2026)
por: Cong, Cao
Publicado: (2026)
Adrenalectomía y receptor 5-HT1A: un análisis microestructural de la conducta alimentaria
por: Verónica Elsa López Alonso
Publicado: (2013)
por: Verónica Elsa López Alonso
Publicado: (2013)
A small‐molecule screen identifies novel aging modulators by targeting 5‐HT/DA signaling pathway
por: Shi‐Wei Ye, et al.
Publicado: (2024)
por: Shi‐Wei Ye, et al.
Publicado: (2024)
Study of Confinement Improvement in Presence of a MARFE in the HT-7 Superconducting Tokamak
por: M. Asif
Publicado: (2006)
por: M. Asif
Publicado: (2006)
Analysis of disruptive discharges during density limit experiments on the HT-7 Tokamak
por: X. Gao
Publicado: (2006)
por: X. Gao
Publicado: (2006)
Precision Measurement of Vibrational Quanta in Tritium Hydride (HT)
por: Cozijn, F. M. J., et al.
Publicado: (2024)
por: Cozijn, F. M. J., et al.
Publicado: (2024)
The generalized Alice HH vs Bob HT problem
por: Janson, Svante, et al.
Publicado: (2025)
por: Janson, Svante, et al.
Publicado: (2025)
Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5‐HT1A Signalling
por: Shaun W. P. Rees, et al.
Publicado: (2024)
por: Shaun W. P. Rees, et al.
Publicado: (2024)
5‐HT 2A receptors in the prelimbic cortex VIP‐expressing interneurons: A mechanism for psychedelic‐induced innate fear attenuation
por: Yuanyuan Wang, et al.
Publicado: (2026)
por: Yuanyuan Wang, et al.
Publicado: (2026)
In Silico Characterization of Bromo‐ DragonFLY Binding to the 5‐ HT 2A Receptor: Molecular Insights Into a Potent Designer Psychedelic
por: Syeda Sumayya Tariq, et al.
Publicado: (2025)
por: Syeda Sumayya Tariq, et al.
Publicado: (2025)
Ejemplares similares
-
CARACTERIZACIÓN DE LA CONDUCTA ALIMENTARIA INDUCIDA POR AGONISTAS 5-HT1A, 5-HT1B, 5-HT2A y 5-HT2C
por: VERÓNICA ELSA LÓPEZ-ALONSO
Publicado: (2009) -
Serotonin 5‐ HT 7 receptor signaling in neuropsychiatric disorders
por: Eunseo Park, et al.
Publicado: (2026) -
The roles of 5‐HT in orofacial pain
por: Zhishan Zou, et al.
Publicado: (2024) -
Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum
por: Jieling Cai, et al.
Publicado: (2024) -
Optimized 5‐HT 2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction
por: Saktimayee M. Roy, et al.
Publicado: (2025)